These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37862877)

  • 21. Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose.
    Essien UR; Sileanu FE; Zhao X; Liebschutz JM; Thorpe CT; Good CB; Mor MK; Radomski TR; Hausmann LRM; Fine MJ; Gellad WF
    J Gen Intern Med; 2020 May; 35(5):1537-1544. PubMed ID: 31965528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration.
    Palis H; Gan W; Xavier C; Desai R; Scow M; Sedgemore KO; Greiner L; Nicholls T; Slaunwhite A
    JAMA Netw Open; 2022 Nov; 5(11):e2243653. PubMed ID: 36416821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individual and county-level variation in outcomes following non-fatal opioid-involved overdose.
    Lowder EM; Amlung J; Ray BR
    J Epidemiol Community Health; 2020 Apr; 74(4):369-376. PubMed ID: 31919146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study.
    Hartung DM; Johnston KA; Hallvik S; Leichtling G; Geddes J; Hildebran C; Keast S; Chan B; Korthuis PT
    J Gen Intern Med; 2020 Nov; 35(11):3188-3196. PubMed ID: 32935311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
    Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
    Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing opioid overdose hotspots for place-based overdose prevention and treatment interventions: A geo-spatial analysis of Rhode Island, USA.
    Samuels EA; Goedel WC; Jent V; Conkey L; Hallowell BD; Karim S; Koziol J; Becker S; Yorlets RR; Merchant R; Keeler LA; Reddy N; McDonald J; Alexander-Scott N; Cerda M; Marshall BDL
    Int J Drug Policy; 2024 Mar; 125():104322. PubMed ID: 38245914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Socio-Demographics and Health Service Use of Opioid Overdose Decedents in Wales: A Cross-Sectional Data Linkage Study.
    Fuller GW; Jones M; Bradshaw CA; Jones J; John A; Snooks H; Watkins A
    Eur Addict Res; 2022; 28(3):226-230. PubMed ID: 35172309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rapid-cycle assessment strategy for understanding the opioid overdose epidemic in local communities.
    Taubenberger S; Spencer N; Chang JC; Paul N; Fabre S; Jagessar B; Trimble D; Roberto R; Gill P; Hulsey E; Arnold A; Hacker K
    Subst Abus; 2021; 42(4):888-895. PubMed ID: 33689674
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.
    Klemperer EM; Wreschnig L; Crocker A; King-Mohr J; Ramniceanu A; Brooklyn JR; Peck KR; Rawson RA; Evans EA
    J Subst Use Addict Treat; 2023 Sep; 152():209103. PubMed ID: 37311520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Housing Instability, Structural Vulnerability, and Non-Fatal Opioid Overdoses Among People Who Use Heroin in Washington Heights, New York City.
    Pérez-Figueroa RE; Obonyo DJ; Santoscoy S; Surratt HL; Lekas HM; Lewis CF; Lyons JS; Amesty SC
    Behav Med; 2022; 48(4):320-330. PubMed ID: 34086534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for persistent fatal opioid-involved overdose clusters in Massachusetts 2011-2021: a spatial statistical analysis with socio-economic, accessibility, and prescription factors.
    Srinivasan S; Pustz J; Marsh E; Young LD; Stopka TJ
    BMC Public Health; 2024 Jul; 24(1):1893. PubMed ID: 39010038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors.
    Chang CY; Jones BL; Hincapie-Castillo JM; Park H; Heldermon CD; Diaby V; Wilson DL; Lo-Ciganic WH
    Breast Cancer Res Treat; 2024 Apr; 204(3):561-577. PubMed ID: 38191684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examining Racial/Ethnic Differences in Patterns of Opioid Prescribing: Results from an Urban Safety-Net Healthcare System.
    Flores MW; Sharp A; Lu F; Cook BL
    J Racial Ethn Health Disparities; 2024 Apr; 11(2):719-729. PubMed ID: 36892815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overdose and mortality risk following a non-fatal opioid overdose treated by Emergency Medical Services in King County, Washington.
    Hood JE; Aleshin-Guendel S; Poel A; Liu J; Collins HN; Sadinle M; Avoundjian T; Sayre MR; Rea TD
    Drug Alcohol Depend; 2023 Dec; 253():111009. PubMed ID: 37984033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
    Crystal S; Nowels M; Samples H; Olfson M; Williams AR; Treitler P
    Drug Alcohol Depend; 2022 Mar; 232():109269. PubMed ID: 35038609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The salience of social context, opioid antagonist use, and prior opioid exposure as determinants of fatal and non-fatal opioid overdoses.
    Zimmerman GM; Douglas SD; Turchan BS; Braga AA
    Health Place; 2023 Jan; 79():102970. PubMed ID: 36638643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
    Pizzicato LN; Johnson CC; Viner KM
    Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
    [No Abstract]   [Full Text] [Related]  

  • 39. Prescription opioid use and non-fatal overdose in a cohort of injection drug users.
    Lake S; Wood E; Buxton J; Dong H; Montaner J; Kerr T
    Am J Drug Alcohol Abuse; 2015 May; 41(3):257-63. PubMed ID: 25699628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids.
    Arakkal AT; Polgreen LA; Chapman CG; Simmering JE; Cavanaugh JE; Polgreen PM; Miller AC
    Pharmacotherapy; 2024 Feb; 44(2):110-121. PubMed ID: 37926925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.